Eisai Pharmaceuticals

Eisai is a pharmaceutical subsidiary of Tokyo-based Eisai Company, is a research-based human health care organization that serves clients throughout the world. The company has been in operation since 1995 and markets products throughout the United States. With sales revenue of more than $3 billion, it serves patients and caregivers. The company works with health care professionals, hospitals and managed care organizations. It employs a staff of over 1,800 people. The company markets products for the treatment of neurological and gastrointestinal disorders. It offers products under the ARICEPT, ACIPHEX, BANZEL, ZONEGRAN and FRAGMIN brands. Eisai maintains a pharmaceutical production and formulation research and development facility in North Carolina. The company s distributors include Caremark and Morris & Dickson Company.

Advance Realty Investors is a privately held, fully integrated real estate investment, development, and management firm headquartered in New Jersey. With a diversified portfolio of premier properties spanning from the Northeast Corridor to other leading markets nationwide, the company focuses on creating developments that elevate excellence and meet the needs of communities and companies. As long-term owners of the majority of the properties they develop, Advance Realty Investors views each project as an opportunity to strengthen existing relationships and establish new ones. Their commitment to mutual trust, respect, and understanding clients' visions drives their pursuit of higher levels of achievement in real estate development. Generated from the website